GPP
Great Point Partners Portfolio holdings
AUM
$154M
This Quarter Return
+18.54%
1 Year Return
-2.36%
3 Year Return
+169.3%
5 Year Return
+292.82%
10 Year Return
+3,519.88%
AUM
$457M
AUM Growth
+$457M
(+0.7%)
Cap. Flow
-$18.1M
Cap. Flow
% of AUM
-3.96%
Top 10 Holdings %
Top 10 Hldgs %
66.05%
Holding
48
New
12
Increased
6
Reduced
8
Closed
11
Top Buys
| 1 |
CNCE
Concert Pharmaceuticals, Inc.
CNCE
|
$37.5M |
| 2 |
Rigel Pharmaceuticals
RIGL
|
$30.1M |
| 3 |
PTC Therapeutics
PTCT
|
$14.5M |
| 4 |
SGYP
Synergy Pharmaceuticals, Inc Common Stock
SGYP
|
$10.5M |
| 5 |
PRTK
Paratek Pharmaceuticals, Inc.
PRTK
|
$10.4M |
Top Sells
| 1 |
Enanta Pharmaceuticals
ENTA
|
$27.7M |
| 2 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$25.8M |
| 3 |
MACK
Merrimack Pharmaceuticals, Inc.
MACK
|
$20.4M |
| 4 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$16.2M |
| 5 |
CLCD
CoLucid Pharmaceuticals, Inc.
CLCD
|
$15.9M |
Sector Composition
| 1 | Healthcare | 80.26% |
| 2 | Technology | 0.97% |
